StockData
Definium Therapeutics, Inc. logo

Definium Therapeutics, Inc. (DFTX) income statement

DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30
$29.12−0.26 (-0.88%)

Close on Nov 18, 2026Market cap $3.91BP/E –Yield –

See a number that looks wrong?